the diasone itself"; also, "the effect of diasone treatment on the tulberculosis of guinea pigs appears to be directly related to the cyanotic effect on the internal organs"; and, "it is doubtful whether a therapeutic effect for diasone has been attained clinically in tuberculosis in man with the sulfonamide or sulfone drugs thus far... In view of the greater sensitivity of the human being to anoxic and anoxemic effects and the fact that such a mechanism appears to explain the favorable results noted on tuberculosis in the guinea pig, it would not seem warranted to continue human experimentation with these drugs at present. . ." That only negative results from the use of such therapy in tuberculosis in human beings can accrue is amply demonstrated by an exhaustive study made by Tice, Sweany, and Davison. 26 They state, "The results of the treatment with both drugs were essentially negative so far as favorable effects on the disease tuberculosis were concerned. A few cases appeared to be injured by the treatment." They, add, however, ". . . nor should our findings discourage further attempts to find a chemotherapeutic agent for a treatment of the disease." To those few who have faith in the possibility of a specific chemotherapy in tuberculosis, there is a close resemblance, except in name, between the application of chemotherapy and of antibiotics. 19 The character of the latter is less exact because the chemical is of unknown composition, while the character of the former is usually known and chosen from synthetic chemicals rather than from naturally occurring materials. However, antibiotic research is not new to the study of tuberculosis, since in 1932,5 just ten years after Fleming described lysozyme, it was shown that this agent did not possess an appreciable inhibitory or bactericidal effect on tubercle bacilli in vitro. It was pointed out also that the action of lysozyme did not appear to be a factor in accounting for any organic susceptibility to tuberculosis in animals. To a great extent, the latter phenomenon is still unexplained by any known factors in the animal economy unless the phagocytes and oxygen tension oif the organs play some part. This, however, does not fully explain the difference occurring in different animal species. The retarding effect of contaminations on the growth of tubercle bacilli in culture was such a routine occurrence in the laboratory that its mechanism was relegated to some simple explanation, such as the pH, exhaustion of the medium, spoilage, etc., until the antibiotics were heralded as therapeutic agents for bacterial diseases.
In 1929 the classic studies of Fleming on penicillin appeared and its usefulness not only in culture for preventing contaminations of gram-negative. forms but its relative lack of toxicity for animals and for leukocytes was pointed out.'4 Until 1940, few reports on penicillin had appeared. Then the Oxford group reported the use of potent concentrates, and today penicillin occupies the topmost position in the list of important antibiotics even though it p-roved of no value in tu-berculosis, even in the test-tube. The list of antibiotic substances produced by molds and fungi is a large one and is still expanding.
Waksman has described a number of the more recent antibiotics, among them actinomycin A and B, streptothricin (1941) from A. lavendulae, and streptomycin (1944) . It is interesting that he notes on page 106 of his 1945 text27 that A. griseus does not form a zone of inhibition around M. tubercihlosis. Since 1944 interest has centered on streptomycin21 rather than on streptothricin, primarily because it is less toxic and possesses greater activity against various gram-negative bacteria and toward streptothricin-resistant organisms. It is prepared from Actinomyces griseus, and its name originated because it was produced by one of the actinomycetes which sporulates and produces aerial mycelia and to which Waksman and Henrici gave the generic name "Streptomyces." In the early work Waksman recovered 30 units per milligram of dry product."6 Since then, Merck & Co. has prepared a product containing 1,000 units per milligram, as tested against E. coli.
A preliminary report by Feldman and Hinshaw12 noted that Waksman and his coworkers had shown by experiments in vitro that streptomycin was capable of exerting marked bacteriostatic and bactericidal effects against a human strain of M. tuberculosis. Because of this in vitro effect and its low toxicity for animals, they studied the effect on guinea-pigs, reaching the conclusion that streptomycin exerted "a striking suppressive effect on tthe pathogenic proclivities in guinea pigs of the human variety of Mycobacterium tuberculosis." The same year Robinson, Smith, and Graessle' pointed out that streptomycin possessed advantages iover streptothricin, particularly as to toxicity and a greater action toward certain gram-negative and gram-positive bacteria in vivo, al-though streptothricin seemed to be more effective than is streptomycin acting in vitro against pathogenic fungi. In a further report, Stebbins, Graessle, and Robinson25 noted that streptomycin is rapidly albsorbed and excreted following parenteral administration, 60 to 80 per cent being excreted in the urine within 24 hours by dogs and monkeys. Peak blood levels were reached within 30 minutes after injection and *then the level declined fairly rapidly within a few hours. Given perorally, relatively small amounts are detected in the blood because of lack of absorption from the gastro-intestinal tract. Streptothricin and streptomycin fed to mice reduced the number of coliform and non-lactose fermenting organisms in the feces, and this was maintained as long as therapy was continued.' Smith and McClosky24 noted that the daily intramuscular injection of 5,000 units of streptomycin over a period of 90 days in guinea-pigs infected with a human strain of tubercle bacilli produced a chemotherapeutic effect superior to that obtained with 0.5 gm. of promin per kg. given orally for the same length of time. On cultures of rabbit's spleen, streptomycin displayed a uniformly low toxicity."5 In adult men, Anderson and Jewell' studied the distribution of 50,000 to 150,000 units per cc. by intravenous, intramuscular, and subcutaneous administration. Streptomycin is not albsorbed after oral administration in amounts sufficient to be detectable in the serum. The serum concentration curves do not differ significantly except during a few minutes after intramuscular or intravenous injection: from 46 to 87 per cent is recovered in the urine within 24 hours. In patients with meningitis, streptomycin diffuses to a slight extent from the blood into the cerebrospinal fluid. Intrathecally, doses up to 20,000 units produce no signs of meningeal irritation. . No toxic reactions followed the single injection of 600,000 units or after continued administration for two to three weeks in doses totalling 2.7 to 18.1 million units. The intravenous or subcutaneous injection of concentrated solutions caused too much discomfort to warrant using these routes. Intravenous infusion can be used without unpleasant symptoms. Intramuscular injections are fairly well tolerated for periods up to one or two weeks, but beyond this severe discomfort results. Reporting on the toxicity of streptomycin for man, Hettig and Adcock note"7 that limited tests of renal and hepatic function together with blood studies before and after administration of streptomycin revealed no evidence of serious toxicity. Reactions such as fever, arth'ralgias, and skin rashes, as well as histamine-like effects, are believed to 'be due to impurities.
In an exhaustive study of its distribution, Kornegay, Forgacs, and Henley'8 found that 5,000 and 10,000 units of streptomycin per kg. in mice produced a maximum blood level of 8 units per cc., or higher, then the concentration dropped rapidly and the drug had disappeared in two hours. Of the organs assayed, the liver and spleen were negative at all times and the kidney concentration was so low that it indicated the drug was present merely in a state preparatory to elimination. In thie guinea-pig, blood levels vary with the route of administration. Variations in blood levels were observed with changes in dosage and it was found in the blood as late as 6 hours after injection. Rabbits retain the drug sufficiently, like guinea-pigs, to permit administration at 3 to 4-hour intervals. After 10,000 units intramuscularly, blood levels range from 10 units at 30 minutes to 1.5 units at 6 hours. In monkeys, blood levels ranged from 25 units at 15 minutes to less than 0.5 unit at 5 hours.
In man, a dose of 30,000 units given every 3 hours intramuscularly will provide a blood level of from 1 months' contact. Our attempts to obtain streptomycin by the method outlined by Dr. Waksman were not very successful because of the destruction of the streptomycin by the acid aloohol used in his procedure. Niot until we used the modified method described by Carter, Clark, Dickman, Loo, Skell, and Strong3 were we able to produce adequa.te and satisfactory amounts for even small-scale experimentation. All appeals to pharmaceutical houses and to the National Research Council failed until the early part of 1946 when we were able to dbtain 0.5 gm. of Merck's streptomycin through Dr. Chester Keefer with titre given against E. coli so that we might run adequate comparison standards with our own preparations. The early preparations using Waksman's broth (tryptone) medium29 contained a high percentage of broth materials adsorbed on the active carbon along with the streptomycin, so that the 'titre per mg. was only about 100 units in these preparations, equaling the reported early titres of Waksman and Merck. By'growing the A. griseus on a nonprotein synthetic medium, although the weight yield was less, the unit yield was about the same and the material was more nearly pure, with a titre comparable to that sent us by Dr. Keefer (about 1,000 units per mg.). This is the material that was used for most of our recent experiments in this report. A purer material also appears desirable since brain-heart infusion has been found to interfere with the action of streptomycin by Wallace et al. 30 Assay
The assay of antibiotics is open to much criticism and is far from being an exact procedure. Many methods have been described for streptomycin,1' 11, 13, 22, 28 and a variety of 'microorganisms have been used for standard test induding E. coli, Staph. aureus, B. circulans, B. subtilis spores, etc., so that even the standard material must be viewed in the light of the test organism. For this reason, all of our tests were made with at least two microorganisms-the E. coli used by Merck for assay and upon which their units depend, and an acid-fast saprophyte termed "Day" (carriled for several decades in our group of stock organisms). Although "Day" grows more rapidly, it is less susceptible to retardation in a poor nutrient than is M. tuberculosis, but it is also slightly more susceptible to cidal action than is the latter. However, with careful evaluation of these fac-tors, this acid-fast saprophyte proved valuable for speedy evaluation of at least short-period retarding actions of streptomycin and, within limitations, as a cl.ear-cut gauge of its presence and activity. In order to compare a titration between E. coli and this acid-fast saprophyte, the test recorded in table 1 was performed, with broth as nutrient.
The findings recorded in table 1 point out the difficulty in defining a unit by the E. coli test when quantitative graded planting is carried out; while with the "Day" culture the definition of the unit is far more distinct in the broth medium. Another reason for preferring the acid-fast saprophyte "Day" was its closer resemblance to the tulbercle bacillus primarily und.er consideratiion in this study.
The effect of streptomycin on the growth of tubercle bacilli in a good or poor nutrient medium
The growth of tubercle bacilli on egg-yolk glycerol mediutm occurs with plaints as low as 108 mg. per cc.; while on a poor nutrient, such as nutrient broth glycerol agar mediums, plants of 1 mg. or more are required to produce successful growth. In the egg-yolk glycerol medium, 100 units of streptomycin per cc. only slightly retard the growth of plants of 0.01 mg. per cc. of tubercle bacilli; while in nutrient glycerol agar medium, 1 unit per cc. of streptomycin produces the same effect as above in retarding the growth of plants of 1 mg. per cc. of tubercle bacilli. Thus it is readily seen that streptomycin possesses at least 100 times the retarding effect on tubercle bacilli in a poor nutrient as compared with its effect in a good nutrient medium.
On the other hand, "Day," an acid-fast saprophyte, grows well on nutrient glycerol agar, and the growth of plants of The tuberculo-static and the tuberculo-cidal action of streptom ycin In order to note the retarding effect of streptomycin on the growth of tubercle bacilli in a good nutrient, concentrations ranging from none to 10,000 units per cc. oif medium were added to the egg-yolk glycerol medium which was then planted wi,th graded amounts of tubercle bacilli. The results of this experiment are recorded briefly in table 2. NOTE: 1,000 units of streptomycin completely inhibit "Day," an acid-fast saprophyte, in the egg-yolk glycerol medium. The heat used to inspissate this medium-15 minutes at 80-85°C.-has no effect on the streptomycin content as shown by assays with E. coli in nutrient broth in which heated streptomycin, 15 minutes in boiling water-bath, gave the same inhibition as when unheated. One unit of streptomycin will inhibit the growth of "Day" in nutrient broth, indicating that the efficiency of the streptomycin is reduced (approximately) to less than 1/100 of its efficiency when in a good nutrient as compared with a poor nutrient medium, such as nutrient broth.
The data recorded in table 2 indicate that 100 units of streptomycin retard small plantings of 10 4 and 1 O6 mg. of human tubercle bacilli, but this amount will only partially retard the growth of 0.01 mg. plantings, 1,000 units being required for complete retardation.
The retarding effect of streptomycinr in blood nutrient is recorded in table 3, which indicates that an intravenous injection of about 20,000 units of streptomycin into a guinea-pig 15 minutes prior to withdrawing the blood for test is required t,o give a high enough concentration to retard complet.ely the growth of human tuberde 'bacilli; 2,000 units proved inadequate for this purpose. t The blood medium was prepared by adding 25 %o of water and 3 %o of glycerol before inspissating at 80 to 850 C. for 15 minutes. "Day," an acid-fast saprophyte reacting like tubercle bacilli to antibiotics in vitro, showed the same retardation by streptomycin as did the tubercle bacilli when planted on this medium. § The number indicates the weeks after planting when growth first appeared.
In order to study the tuberculocidal action of streptomycin, varying concentrations were added to fine suspensions of tuberde bacilli in saline and in the blood (citrated). The mixtures were kept at 370 C. up to one week, after which.the streptomycin was removed by washing and separation by centrifugation and the bacilli were planted on a good nutrient medium (glycerol egg-yolk) with I10 the results recorded in table 4 for the saline suspension and in table 5 for the blood suspension. weeks at 3 70 C. at which growth
The blood was treated with oxalic acid as is used for the diagnostic cultures for tuberde bacilli before planting. This was not necessary with the physiologic saline test.
The findings are clbvious, for the talbles show that even 10,000 units of streptomycin in saline do not destroy the tuberde bacilli within one week; while in blood, 1,000 units of conitinuous contact are without effect after one week, and 10,000 units for several days have an apparent effect only on small numbers of bacilli (1 0-' mg.), but not on 0.01 mg. per cc. during a week of contact.
Results of streptomycin treatment in vivo
The results recorded by previous authors leave no doubt but that streptomycin appropriately applied will retard the development of tubercullosis in the guinea-pig; but it must be recognized that this alone, though of great academic significance to chemotherapy, does not guarantee that prolionged application of streptomycin as a retardant to human tulberculosis would be justified where the entire pathological picture is much more complicated than is a single primary animal inoculation with a highly virulent tuberde bacillus. However, in order to gain an insight into this mechanism, only a pie. 1 few typical animal experiments will be briefed. The first, as recorded in table 6 , depicts the course of infection and treatment of 4 guinea-pigs and 4 controls given an intravenous injection of 1 mg. of a fine suspension of virulent human tubrcle bacilli (cf. ref. 7) . Treatment was started immediately with several daily subcutaneous injections of streptomycin (9,000 units a day) given each treated guinea-pig. The purpose was to attack the bacilli with streptomycin immediately upon their entrance into the body, to con- Treatment was initiated with intravenous infection and continued until the 28th day. The treated animal dying on the 43rd day showed definitely that progression followed cessation of treatment, to a termination in less time than was required for the con'trols to die after initial infection.
The results recorded in table 6 leave no doubt of the retarding effect of streptomycin on tulberculosis in the guinea-pig, but it is also evident that this effect lasts only so long as treatment continues. There is no evidence that in the amounts used it is able to destroy tubercle bacilli in vivo.
Accumulation of streptomwycin in the organs In view of the possibility of the accumulation of streptomycin in certain organs, which, if true, would serve to prolong its effect beyond the period of treatment, the organic persistence was studied in guinea-pigs and mice with the results recorded in table 7.
The findings recorded in table 7 do not lend support to the assumption that there is an accumulation of streptomycn in the organs of the guinea-pig or mouse after repeated suibcutaneous injections.
Adsorption of streptomycin by tubercle bacilli and by the tubercle In order to note whether or not there is a selective adsorption of streptomycin in vitro or in vivo, an experiment was performed with suspensions of tubercle bacilli (viable and nonviable) to which streptomycin had been added. After a certain interval of time, the bacilli and suspending fluid were assayed for streptomycin, with the results recorded in talble 8.
The data recorded in table 8 present no evidence of a selective adsorption of streptomycin by tubercle bacilli.
In order -to gain an insight into the adsorption of streptomycin by tfhe tubercle and its contained tu'bercle bacilli, 100 mg. of viable tufbercle bacilli were injected ¶sulbcutaneously into a inumber of guinea-pigs 10 days prior to streptomycin treatment. The streptomycin was given in three doses intravenously at hourly intervals for a total of 100,000 units. The blood was obtained for streptomycin examination by cardiac puncture one hour after the last intravenous injection of streptomycin, at which time the animal was killed and the tubercle and its contained pus were removed with aseptic pre- cautions. The blood and tuberde (ground) were assayed for streptomycin, using adid-fast saprophyte "Day" as test organism. The data recorded in table 9 do not indicate the presence, within an hour of the last injection, of an appreciable amount of streptomycin in the tubercle in guinea-pigs after the intravenous injection of a total of 100,000 units in three divided hourly doses.
Taible 10 shows the inability of relatively large amounts of streptomycin to destroy acid-fast organisms and tubercle bacilli in vivo.
The results recorded in table 10 do not appear to justify the conclusion that streptomycin is alble to destroy acid-fast saprophytes or mammalian tubercle bacilli in vivo, even when used subcutaneously in daily amounts of a half million units per kilo.
Summary and conclusions 1. Streptomycin properly administered and in proper dosage is capable of retarding the development or growth of human tubercle bacilli, both in vitro (in good nutrient mediums as well as in poor ones) and in vivo.
2. The concentration of streptomycin required to retard the growth of tubercle bacilli in vitro in good nut-rient medium can only be attained in vivo for a 'brief period by any route of administration or amount of streptomycin that can 'be used even with the present high assay unit preparations. There is no evidence availaible at present to indicate that streptomycin enters the important organs in appreciable amount for any significant time although it is present in the blood, or that it accumulates in these organs.
4. There is no evidence at present that tubercle bacilli adsorb or absoirb streptomycin or that it accumulates in .these bacilli in vitro or in vivo.
5. To the best of our knowledge, streptomycin is a metabolite of A ctinomyces griseus and is not tulberculocidal in reasonable amounts, but it produces its effects in vivo, and in vitro primarily, as a retardant of the growth of tubercle bacilli when they are actively developing or reproducing. It appears to be a tuberculo-toxic metabolite of the A ctinomyces griseus, aotive by retarding tutberculoanabolism. In the usual case of clinical tuberculosis in man, the bacilli appear to reproduce and develop only at irregular periods undeterminable by clinical means and over long periods of time, and this markedly reduces the applicability of a retardant without tuberculocidal action for use in human tuberculosis.
6. How much further the purity and dosage of streptomycin can be increased to achieve ihigher concentrations for use in man remains for future laboratory investigations to disclose. Academically, however, streptomycin is another encouraging milestone for those who have had faith in a chemotherapy for tuiberculosis-the sulfones as retardants for guinea-pig tuberculosis, and now the antibiotic streptomycin as a metabolite retardant, interfering with tuberculo-anabolism. This makes its application limited, if at all possible, in human tuberculosis, but it may yet indicate the selective tuberculocide through laboratory experiment.
